Skip to content
Sign in

MEDI · ARCA · ETF

Harbor Health Care ETF (MEDI) Price, Holdings & Fees

$462.14+0.75%+$3.46End-of-day price as of Oct 9, 2026

Harbor Health Care ETF (MEDI) closed at $462.14 on Oct 9, 2026, up 0.75% from the previous close of $458.68.

Share price, past year

1Y +16.65%

52-week range $377.46 – $464.40. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$462.14
Sep 30, 2026$446.21
Aug 31, 2026$456.11
Jul 31, 2026$453.71
Jun 30, 2026$429.12
May 29, 2026$441.25
Apr 30, 2026$440.44
Mar 31, 2026$425.21
Feb 27, 2026$422.17
Jan 30, 2026$392.53
Dec 31, 2025$386.45
Nov 28, 2025$382.16
Oct 31, 2025$400.75

Key statistics

Expense ratio
0.80%
as of Oct 31, 2025
Net assets
$41.2M
as of Jul 31, 2026
Holdings
44
as of Jul 31, 2026
52-week range
$377.46 – $464.40

Harbor Health Care ETF's expense ratio is 0.80%: $80.00 a year on $10,000 invested.

Holdings

Harbor Health Care ETF held 44 investments worth $41.21M as of Jul 31, 2026. Its largest holding was Eli Lilly & Co, at 20.78% of the fund.

Harbor Health Care ETF largest holdings by share of net assets
#Holding% of fundValue
1Eli Lilly & Co20.78%$8.56M
2Ascendis Pharma A/S13.61%$5.61M
3Gilead Sciences Inc5.10%$2.10M
4Rhythm Pharmaceuticals Inc4.02%$1.66M
5AbbVie Inc3.09%$1.27M
6Intuitive Surgical Inc2.83%$1.17M
7Cencora Inc2.75%$1.13M
8Revolution Medicines Inc2.54%$1.05M
9Insmed Inc2.52%$1.04M
10Merck & Co Inc2.47%$1.02M
11Boston Scientific Corp2.40%$989.09K
12Natera Inc2.26%$930.47K
13Abivax SA2.16%$891.80K
14Insulet Corp2.10%$864.12K
15Argenx SE2.07%$854.67K
16Vaxcyte Inc2.06%$848.79K
17McKesson Corp2.02%$833.93K
18Legend Biotech Corp1.91%$786.80K
19Danaher Corp1.73%$711.09K
20Guardant Health Inc1.54%$635.81K
21Novo Nordisk A/S1.46%$601.68K
22IDEXX Laboratories Inc1.40%$578.08K
23UnitedHealth Group Inc1.39%$572.70K
24PTC Therapeutics Inc1.31%$538.16K
25Vertex Pharmaceuticals Inc1.22%$502.39K

Top 25 of 44 holdings, as of Jul 31, 2026. Percentages are of the fund's net assets.

What the fund owns

Harbor Health Care ETF holdings by asset type
Asset type% of fund
Stocks99.61%
Harbor Health Care ETF holdings by country, largest 7
Country% of fund
United States76.66%
Denmark15.07%
Netherlands2.59%
France2.53%
Cayman Islands1.91%
Canada0.51%
Switzerland0.33%

Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.

Monthly total returns

Over the 3 months to Jul 31, 2026, Harbor Health Care ETF's total return was +8.42%, as reported to the SEC.

Harbor Health Care ETF monthly total returns
MonthTotal return
Jul 31, 2026−4.46%
Jun 30, 2026+9.34%
May 31, 2026+3.79%

The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.

Fund profile

Name
Harbor Health Care ETF
Ticker
MEDI
Exchange
ARCA
Fund type
ETF
Trust
Harbor ETF Trust
SEC series ID
S000077996
SEC CIK
0001860434
Fractional shares
No

Recent SEC filings

Shareholder reports and prospectuses are filed by Harbor ETF Trust, the trust behind Harbor Health Care ETF, and cover all of its funds.

Frequently asked questions

What is MEDI's price?

Harbor Health Care ETF (MEDI) closed at $462.14 on Oct 9, 2026, up 0.75% from the previous close of $458.68.

What is MEDI's expense ratio?

Harbor Health Care ETF's expense ratio is 0.80%: $80.00 a year on $10,000 invested.

What does MEDI hold?

Harbor Health Care ETF held 44 investments worth $41.21M as of Jul 31, 2026. Its largest holding was Eli Lilly & Co, at 20.78% of the fund. Its five largest holdings were Eli Lilly & Co, Ascendis Pharma A/S, Gilead Sciences Inc, Rhythm Pharmaceuticals Inc, AbbVie Inc.

How has MEDI performed?

Over the 3 months to Jul 31, 2026, Harbor Health Care ETF's total return was +8.42%, as reported to the SEC.

Sources and methodology

Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jul 31, 2026 (filed Sep 25, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Oct 31, 2025. Prices are generated sample data for development. Data sources and disclosures